Radioligand Therapy (RLT) Market Poised to Reach USD 10.91 Billion by 2035, Driven by Advances in Precision Oncology
Radioligand therapy (RLT) is emerging as one of the most promising approaches in precision oncology, offering targeted treatment options for patients with difficult-to-treat cancers. According to recent market research, the global Radioligand Therapy (RLT) Market is projected to grow from USD 3.15 billion in 2025 to USD 10.91 billion by 2035, registering a robust CAGR of 13.2% during the forecast...